Last edition
News about
Dr. Reddy's enters the trade generics business in India
Dr. Reddy's enters the trade generics business in India
Aurobindo Pharma Ltd's subsidiary to withdraw application for EU Marketing Authorization of two biosimilars
Dr Mansukh Mandaviya addresses IPA’s 8th Global Pharmaceutical Quality Summit: Focus on Patient Centricity and the Future of Manufacturing and Quality
H.E.L Group Unveils New State-of-the-Art Global Headquarters to Drive Innovation and Collaboration
Overseen by interim Operational Director, Damian Slater, the move to new purpose-designed facilities supports the Company’s continued expansion and plans for future growth.
Quantiphi Partners with Pharmarack and Snowflake to Revolutionize India's Pharma Industry with AI-Driven Innovation
Gufic receives approval from NMPA, China for Prilocaine API
Gufic receives approval from NMPA, China for Prilocaine API
NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine for the US market
NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine for the US market
USFDA completes inspection at Dr Reddy's Laboratories Ltd's Bollaram API unit
USFDA completes inspection at Dr Reddy's Laboratories Ltd's Bollaram API unit
Murata ID Solutions and University of Parma conference explores ‘RFID and Sustainability’ research and outlines new E-ROI tool
Natco Pharma receives EIR from USFDA for Vizag facility
Natco Pharma receives EIR from USFDA for Vizag facility
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy